-
<![CDATA[How Real-World Cases Inform Biologic Decision-Making in HS]]>
22 Dec 2025 21:27 GMT
… long-term data, despite manageable candidiasis risk. TNF-α inhibitors are now …
-
Clinico-Epidemiological Prediction of Adverse Outcomes in Acute Pediatric Poisoning: A Risk Prediction Nomogram Approach
22 Dec 2025 18:48 GMT
… infection/disfigurement, and oral candidiasis. The length of stay (LOS … sequelae, skin infections, and oral candidiasis were significantly higher among pre …
-
SCYNEXIS Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Price Requirement
22 Dec 2025 13:00 GMT
… of SCY-247 for invasive candidiasis infections. SCY-247 is an … ) for the treatment of vulvovaginal candidiasis (VVC) and for reduction in … of SCY-247 for invasive candidiasis infections, and the potential benefits …
-
Are Biologics Safe in Patients With Psoriasis and Cancer?
22 Dec 2025 02:20 GMT
… .79; P = .002), particularly oroesophageal candidiasis and upper respiratory tract infections …
-
Granular Parakeratosis in an HIV-Infected Patient Exposed to Benzalkonium Chloride: A Case Report
20 Dec 2025 08:31 GMT
… diagnosed with GP with concomitant candidiasis. Tinea corporis and tinea cruris … our initial hypothesis that the candidiasis was secondary, resolving as the … process for GP complicated by candidiasis in an HIV-infected individual …
-
IT Jobs, Gym Culture and Poor Sleep Drive Rise in Male Infertility
20 Dec 2025 10:51 GMT
… mostly caused by bacterial imbalance, candidiasis or yeast infection, trichomoniasis, which …
-
Bimekizumab for Hidradenitis Suppurativa from Trials to Real Life: A Review of the Published Literature
19 Dec 2025 14:01 GMT
… potential increased risk of mucocutaneous candidiasis with IL-17 blockade. This … regards candida and bimekizumab, oral candidiasis were the most frequently reported … is higher.
However, although most candidiasis cases reported in trials and …
-
<![CDATA[Evaluating the Safety Profile of IL-17 Inhibitors in Psoriatic Disease]]>
19 Dec 2025 16:29 GMT
… event is mucosal or oral candidiasis, which is typically mild, manageable …
-
<![CDATA[Considering Biologics and Shared Decision-Making in Moderate to Severe Plaque Psoriasis: Part 3]]>
18 Dec 2025 19:18 GMT
…
Adherence requirements
Safety discussions (especially candidiasis risk with IL-17 inhibitors …
-
CorMedix Therapeutics Announces Positive Data From Ongoing Real World Evidence Study of DefenCath
18 Dec 2025 13:00 GMT
… treatment of candidemia and invasive candidiasis in adults, with an ongoing …